Form 4 for ACET Adicet Bio, Inc.
Accepted 2022-07-07 00:00:00 ET · period of report 2022-07-05 · accession 0001209191-22-041499 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-07 | 2022-07-05 | ACET | Aftab Blake | CSO | S - Sale | $14.50 | -1,363 | 52.9K | -3% | -$19.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-05 | S | D | 1,363 | $14.50 | 52,903 | D | — | — | (F2) Includes 1,363 shares purchased under the Issuer's Amended and Restated 2018 Employee Stock Purchase Plan on June 30, 2022 in a transaction that is exempt under Rule 16b-3(c) and 16b-3(d). |